Detalhe da pesquisa
1.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697165
2.
Deep learning-based MR-to-CT synthesis: The influence of varying gradient echo-based MR images as input channels.
Magn Reson Med
; 83(4): 1429-1441, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593328
3.
PREDICT: model for prediction of survival in localized prostate cancer.
World J Urol
; 34(6): 789-95, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26420595
4.
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study.
Clin Transl Radiat Oncol
; 46: 100742, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38440792
5.
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability.
Int J Radiat Oncol Biol Phys
; 118(2): 378-389, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633499
6.
Advancing the treatment of localized prostate cancer with MR-guided radiotherapy.
Prostate Cancer Prostatic Dis
; 26(1): 50-52, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550217
7.
Comparing adaptation strategies in MRI-guided online adaptive radiotherapy for prostate cancer: Implications for treatment margins.
Radiother Oncol
; 186: 109761, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348607
8.
An ESTRO-ACROP guideline on quality assurance and medical physics commissioning of online MRI guided radiotherapy systems based on a consensus expert opinion.
Radiother Oncol
; 181: 109504, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736592
9.
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.
Radiother Oncol
; 185: 109713, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178932
10.
Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study-An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy.
Pract Radiat Oncol
; 13(3): e261-e269, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462619
11.
Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.
Radiother Oncol
; 186: 109803, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437609
12.
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus.
Int J Radiat Oncol Biol Phys
; 116(3): 503-520, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596346
13.
Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know.
Eur Urol
; 82(2): 149-151, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031164
14.
Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.
Front Oncol
; 12: 962897, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36132128
15.
How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
Eur Urol
; 82(6): 578-580, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167598
16.
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer.
Eur Urol
; 82(3): 252-257, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953603
17.
Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands.
Radiother Oncol
; 177: 134-142, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328090
18.
Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.
Radiother Oncol
; 167: 127-132, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968470
19.
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.
Radiother Oncol
; 162: 98-104, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214614
20.
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.
J Clin Oncol
; 39(7): 787-796, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471548